PYC pyc therapeutics limited

Ann: Annual Report to shareholders, page-9

  1. 5,184 Posts.
    lightbulb Created with Sketch. 1681
    That near ridiculous current level of pricing is due to our partner/ investor to come onboard.
    Once that is concluded (as clearly nobody is accumulating but stock is parked) then
    we should instantly double in price with triple the amount by the time CNS and additional ocular pipelines are outlined.

    Chairman has outlined that we saw substantial shareholder return for the past year coming into June and he reiterated that wewill again see substantial returns for the coming 12 months.
    300 to 400 % is my guess, all depending on the size and conditions of the funding arrangements. A alrge funding will accelerate many times lines, and as Linsanity pointed out, all MC estimates are then out of the window, so to speak, as expectations could be massively
    outpaced by reality.

    Market currently might also wait for more info to gauge this properly, apart from the tick of positive large animal results.

    Lots of catching up to do once funding is locked in in terms of MC.

    all IMO
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$1.15
Change
0.020(1.77%)
Mkt cap ! $670.7M
Open High Low Value Volume
$1.15 $1.18 $1.11 $172.3K 151.3K

Buyers (Bids)

No. Vol. Price($)
1 592 $1.15
 

Sellers (Offers)

Price($) Vol. No.
$1.16 4211 1
View Market Depth
Last trade - 16.10pm 20/06/2025 (20 minute delay) ?
PYC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.